Tora-Dol 20 mg/ml oral drops

Tora-Dol is a widely recognized brand of ketorolac tromethamine, a potent non-steroidal anti-inflammatory drug (NSAID) used for the short-term management of moderate to severe pain. The product shown in the image is an oral drop solution (gocce orali) specifically formulated for the Italian market.

The brand was originally developed and commercialized by Syntex Corporation, a company that was later acquired by Roche. However, in many European markets, including Italy, the rights to the brand and its distribution were acquired by the Italian pharmaceutical group Recordati. The manufacturing of this specific product typically takes place in Italy at Recordati's specialized production facilities.

Recordati is a prominent international pharmaceutical group, listed on the Italian Stock Exchange, with a significant presence in specialty and primary care medicines as well as rare disease treatments. The company maintains full ownership of the brand within its primary territories, managing everything from R&D to distribution.